1-3 of 3
William Casey Wilson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNMT3A Mutations Enhance T-ALL Survival, Which Is Reversed By JAK/STAT Inhibition

Wangisa M.B. Dunuwille, William Casey Wilson, Nancy Issa, Won Kyun Koh, Wentao Han, Grant A Challen
Journal: Blood
Blood (2022) 140 (Supplement 1): 8756–8757.
https://doi.org/10.1182/blood-2022-167136
Published: 2022
Journal Articles

AO-176, a Differentiated Clinical-Stage Anti-CD47 Antibody, Demonstrates Potent Anti-Tumor Activity across Multiple Preclinical Models of B Cell Neoplasms

William Casey Wilson, John O Richards, Gabriela Andrejeva, Benjamin J Capoccia, Robyn J Puro, Mike J Donio, Ronald R Hiebsch, Arun K Kashyap, Daniel S Pereira
Journal: Blood
Blood (2021) 138 (Supplement 1): 2277.
https://doi.org/10.1182/blood-2021-152896
Published: 2021
Journal Articles

AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma As a Single Agent and in Combination with Approved Therapeutics

William Casey Wilson, PhD, John Richards, PhD, Robyn J Puro, PhD, Gabriela Andrejeva, PhD, Ben J Capoccia, PhD, Mike J Donio, Ronald R Hiebsch, BS, Prabir Chakraborty, PhD, Victoria Sung, PhD, Daniel S Pereira, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-139655
Published: 2020